Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
09/2010
09/30/2010US20100247514 Gamma secretase modulators
09/30/2010US20100243971 Photochromic benzopyrans
09/30/2010CA2756172A1 Inhibitors of hepatitis c virus replication
09/30/2010CA2756067A1 Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy
09/30/2010CA2754176A1 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
09/29/2010EP2233140A1 Bicyclic amides for enhancing glutamatergic synaptic responses
09/29/2010EP2231663A2 Fused heterocyclic derivatives and methods of use as c-met inhibitors
09/29/2010EP2231656A1 Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors
09/29/2010EP1638957B1 N-heterocyclyl phenyl-substituted cyclic ketoenols
09/29/2010EP1534695B1 Tyrosine kinase inhibitors
09/29/2010EP1421074B1 Novel compounds
09/29/2010CN1965052B Single-layer organic el device
09/29/2010CN101115758B Amorphous taclolimus solid dispersion having an enhanced solubility and pharmaceutical composition comprising same
09/28/2010US7803944 Viral polymerase inhibitors
09/28/2010US7803808 rapamycin analogues used for inducing immunosuppression, the stimulation of neuron regeneration or the treatment of cancer, fungal infections, transplant rejection, graft vs. host disease, autoimmune disorders, inflammatory and fibrotic diseases, and in the regulation of wound healing
09/28/2010CA2387016C Acrylamide derivatives as fab i inhibitors
09/23/2010WO2010107765A1 Bicyclic compounds as inhibitors of diacylglycerol acyltransferase
09/23/2010WO2010106366A1 Fk506 and fk520 analogues and their pharmaceutical uses
09/23/2010US20100239664 Forms of rifaximin and uses thereof
09/23/2010DE102009001570A1 Lilial-Surrogat Lilial surrogate
09/23/2010CA2755251A1 Bicyclic compounds as inhibitors of diacylglycerol acyltransferase
09/22/2010EP2229381A1 Gamma secretase modulators
09/22/2010EP2229375A1 Gamma secretase modulators
09/22/2010EP1978967B1 Quinazolinone derivatives as vanilloid antagonists
09/22/2010EP1896477B1 Aspartyl protease inhibitors
09/22/2010EP1765830B1 Mitotic kinesin inhibitors
09/22/2010CN101842376A Tetracyclic indole derivatives and their use for treating or preventing viral infections
09/21/2010US7799913 Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses
09/21/2010US7799801 Heterocyclic aromatic compounds useful as growth hormone secretagogues
09/21/2010US7799782 P38 inhibitors and methods of use thereof
09/21/2010US7799780 4-(5,6-Dihydro-8H-imidazo[5,1-c][1,4]oxazin-8-yl)benzonitrile, used for the treatment of hypokalemia, hypertension, congestive heart failure, renal failure, restenosis, atherosclerosis, metabolic syndrome, obesity, hyperaldosteronism, nephropathy, myocardial infarction, edema and fibrosis
09/21/2010US7799775 Pyrimidine derivatives
09/21/2010US7799772 Pyrido-and pyrimidopyrimidine derivatives as anti-profilerative agents
09/21/2010CA2445068C Azo compounds for type i phototherapy
09/21/2010CA2444123C Novel arylsulfonamides as antiviral agents
09/21/2010CA2440559C Novel non-imidazole compounds
09/16/2010WO2010104721A1 Mineralocorticoid receptor antagonist and methods of use
09/16/2010WO2010104205A1 7-cycloalkylaminoquinolones as gsk-3 inhibitors
09/16/2010WO2010103381A1 Spirocyclic piperidine derivatives as trpm 8 modulators
09/16/2010WO2010102778A2 Substituted 3-aminoisoxazolopyridines as kcnq2/3 modulators
09/16/2010WO2010075204A3 Gamma secretase modulators
09/16/2010US20100235950 Pesticidal plant extract containing loline derivatives
09/16/2010US20100234609 Fused ring spiroketal derivative and use thereof as anti-diabetic drug
09/16/2010US20100234419 Substituted 3-aminoisoxazolopyridines as kcnq2/3 modulators
09/16/2010US20100234348 Compositions and methods for potentiating antibiotic activity
09/16/2010CA2755120A1 7-cycloalkylaminoquinolones as gsk-3 inhibitors
09/16/2010CA2754934A1 Substituted 3-aminoisoxazolopyridines as kcnq2/3 modulators
09/16/2010CA2754890A1 Novel bicyclic heterocycles
09/16/2010CA2751901A1 Mineralocorticoid receptor antagonist and methods of use
09/15/2010EP2227476A1 Tricyclic triazolic compounds
09/15/2010EP2227475A1 Isoxazolopyridine derivatives for use in the treatment of hif-mediated conditions
09/15/2010EP2227469A1 Mapk/erk kinase inhibitors
09/15/2010EP1351681B1 Implantable device containing resorbable matrix material and anti-proliferative drugs for preventing or treating failure of hemodialysis vascular access and other vascular grafts
09/15/2010CN101835779A Purine derivatives useful as PI3 kinase inhibitors
09/15/2010CN101835776A Fused imidazoles for cancer treatment
09/15/2010CN101830921A Novel method for activating 7-halogen of fluoroquinoline-3carboxylic acid and application thereof in forming side chain with secondary amine by using condensation
09/15/2010CN101006091B Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament
09/14/2010US7795447 4-(Acylaminoacetylamino)imidazole derivatives, e.g., methyl 3-(4-{2-[2-(3,5-Difluorophenyl)acetylamino]pentanoylamino}imidazol-1-yl)butyrate; treating neurodegenerative and/or neurological disorders such as Alzheimer's disease and Down's Syndrome
09/14/2010US7795440 N-substituted tricyclic 1-aminopyrazoles as inhibitors for the treatment of cell proliferative disorders
09/14/2010US7795431 Terrylene and quaterrylene derivatives
09/14/2010US7795273 Pyrazolo[1,5-a]pyridine-3-carboxylic acids as EphB and VEGFR2 kinase inhibitors
09/14/2010US7795267 G protein-coupled receptor antagonists such as phenyl tetrahydro-3-oxo-1,1-diphenyl-3H-oxazolo[3,4-a]pyrazine-7(1H)-carboxylate, used for treating cancer, Alzheimer's disease, dementia, eating disorder, hypertension, glandular disorders, diabetes and hyperlipemia
09/14/2010US7795261 substance P receptor blockers, such as [2R-trans]-{2-benzyl-4-[4-(1-pyrazin-2-yl-pyrrolidin-3-yl)-piperazin-1-yl]-piperidin-1-yl}-(3,5-bis-trifluoromethyl-phenyl)-methanone, used for treating schizophrenia, emesis, anxiety and depression, irritable bowel syndrome, sleep disorders, pain and inflammation
09/14/2010US7795260 ecteinascidin analogues used for the treatment of of leukaemia, lung cancer, colon cancer, kidney cancer, melanoma, prostate cancer, ovarian cancer, breast cancer, pancreatic epitheloid carcinoma, and cervix epitheloid carcinoma; antitumor and anticarcinogenic agents
09/14/2010US7795253 Condensed imidazole derivatives as aromatase inhibitors
09/14/2010US7795251 such as 3-[4-(tert-Butyl-dimethyl-silanyloxy)-phenyl]-7-hydroxy-3,4-dihydro-benzo[e][1,3]oxazin-2-one, inhibitors macrophage migration inhibitory factor isomerase activity; treatment of vision defects, ischemia, inflammatory, autoimmune, bone, nervous system, cardiovascular and gastrointestinal disorders
09/14/2010US7795246 mixture with surfactants; improvd bioavailability, stability; oral administering
09/14/2010CA2594789C New polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations
09/14/2010CA2549431C Optically active quaternary ammonium salt having axial asymmetry and process for producing .alpha.-amino acid and derivative thereof with the same
09/10/2010CA2753730A1 Inhibitors of beta-secretase
09/09/2010US20100227848 Oxo bridged diazepan orexin receptor antagonists
09/08/2010EP2226325A1 Process for production of 4-(substituted phenyl)hexahydropyridoý2,1-c¨ý1,4¨oxazin-6-one
09/08/2010EP2226320A1 Process for production of heterocycle-substituted pyridine derivative
09/08/2010EP2225250A2 Bicyclic ppat inhibitors as antibacterial agents
09/08/2010EP2225234A1 Herbicidal compounds based on n-azinyl-n'-pyridylsulphonylureas
09/08/2010EP2225227A2 Compounds
09/08/2010EP2007770B1 Imidazo compounds
09/08/2010EP0770132B1 New streptogramines
09/08/2010CN101827845A Cgrp antagonists
09/08/2010CN101824163A Process for preparing a synergistic stabilizer mixture
09/08/2010CN101824043A Compositions useful as inhibitors of protein kinases
09/08/2010CN101027297B Macrocyclic beta-secretase inhibitors
09/07/2010US7790764 Biologically active macrolides, compositions, and uses thereof
09/07/2010US7790741 Imidazothiazoles and imidazoxazoles
09/07/2010US7790726 chemokine receptor antagonists such as 6-Chloro-3-{2-[4-(4-chloro-3-methoxy-phenyl)-4-hydroxy-piperidin-1-yl]-2-oxo-ethyl}-3H-benzooxazol-2-one, having in vivo antiinflammatory activity
09/07/2010US7790716 fatty acid biosynthesis inhibitors such as E)-3-(6-aminopyridin-3-yl)-N-methyl-N-(1-methyl-1H-pyrrolo[2,3-b]pyridin-3-ylmethyl)acrylamide, used fro the treatment of bacterial infections; antibiotics
09/07/2010US7790714 Oxadiazoanthracene compounds for the treatment of diabetes
09/07/2010US7790713 Inhibitors of interleukin-1β converting enzyme
09/07/2010US7790709 Heterocyclic compounds, methods of making them and their use in therapy
09/07/2010US7789610 Methods for preventing/treating damage to sensory hair cells and cochlear neurons
09/07/2010CA2465079C Substituted thiene-3-ylsulphonylamino(thio)carbonyltriazolin(ethi)ones
09/02/2010WO2010098487A1 Nitrogen-containing fused heterocyclic compounds and their use as beta amyloid production inhibitors
09/02/2010US20100222579 Process for the Preparation of Delmopinol and Derivatives Thereof
09/02/2010US20100222335 Process For The Preparation Of N,N'-Disubstituted Oxabispidines
09/02/2010US20100222302 Novel Antibacterial Compounds
09/02/2010US20100221331 Pharmaceutical compositions comprising colloidal silicon dioxide
09/02/2010US20100219063 Oxidative degeneration products of atorvastatin calcium
09/02/2010CA2753696A1 Nitrogen-containing fused heterocyclic compounds and their use as beta amyloid production inhibitors
09/01/2010EP2222636A2 Selective androgen receptor modulators (sarms) and uses thereof
09/01/2010EP2004657B1 Condensed imidazole derivatives as aldosterone synthase inhibitors
1 ... 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... 220